Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Abbas Madani is active.

Publication


Featured researches published by Abbas Madani.


Pediatric Nephrology | 2003

Glomerular diseases in Iranian children: clinico-pathological correlations

Abbas Madani; Daryoush Fahimi; Seid Taher Esfehani; Parvin Mohsseni; Nematollah Atayee; Mahmood Ahmadi; Fatemeh Elmi; Marziyeh Haddadi

Glomerular disease constitutes an important part of renal disease. The purpose of this study was to describe and correlate the types of glomerular diseases reported in native kidney biopsy specimens and their clinical presentations in Iranian children. The medical records and pathological diagnoses of patients with glomerular disease whose native kidney biopsy specimens were received by our hospital during a 10-year period were reviewed. In each patient, pathological diagnosis, clinical presentation, age at onset of disease, gender, and presence of nephrotic proteinuria, hematuria, and hypertension, were determined. Minimal-change disease was the most frequent glomerular disease and nephrotic syndrome was the most frequent clinical presentation encountered. For each disease, correlations between the clinical presentation and pathological diagnosis were made. This study describes various glomerular diseases encountered in Iranian children, with their respective clinical presentations.


The Journal of Urology | 2010

Vesicoureteral Reflux and Primary Bladder Neck Dysfunction in Children: Urodynamic Evaluation and Randomized, Double-Blind, Clinical Trial on Effect of α-Blocker Therapy

Abdol-Mohammad Kajbafzadeh; Nima Baradaran; Zhina Sadeghi; Ali Tourchi; Parisa Saeedi; Abbas Madani; Neamatollah Ataei; Ali Mohammad Taghavinejad; M. Javad Mohsseni

PURPOSE Primary bladder neck dysfunction has been under diagnosed as a treatable cause of vesicoureteral reflux. We evaluated the effect of prazosin administration on vesicoureteral reflux resolution and urodynamic parameters in children with idiopathic primary reflux and primary bladder neck dysfunction. MATERIALS AND METHODS A total of 62 children (mean ± SD age 7.9 ± 2.4 years) with documented vesicoureteral reflux and urodynamics proved primary bladder neck dysfunction were randomized to receive either 0.025 mg/kg α-blocker (prazosin, 40 patients) or placebo (22) nightly for 1 week with a subsequent increase to 2 divided doses. Patients were followed for 12 months with clinical evaluation and uroflowmetry performed every 2 months, and each patient underwent complete urodynamic study at 6-month intervals. RESULTS In the placebo group no uroflowmetry or urodynamic parameter changed significantly at 1-year followup. A 60% decrease in reflux grade was observed in the treatment group compared to 17% in the placebo group. Mean maximal detrusor pressure, post-void residual and opening time were significantly decreased in both followup sessions in the prazosin group (p <0.05). Average flow rate improved from 4.30 to 12.80 ml per second at 6 months and to 13.10 ml per second at 12 months (both p <0.05). CONCLUSIONS Special attention should be given to secondary causes of vesicoureteral reflux (such as primary bladder neck dysfunction, an underdiagnosed entity in children), since conventional treatment will most likely fail if these conditions are not addressed promptly. In this study prazosin was effective therapy for children with vesicoureteral reflux and primary bladder neck dysfunction.


Pediatric Nephrology | 2009

Comparison between fractional excretions of urea and sodium in children with acute kidney injury

Daryoosh Fahimi; Saeed Mohajeri; Niloufar Hajizadeh; Abbas Madani; Seyed Taher Esfahani; Neamatollah Ataei; Parvin Mohsseni; Malektaj Honarmand

Fractional excretion of sodium (FENa) has been said to be the most sensitive index for differentiating prerenal failure (PRF) from intrinsic renal failure (IRF). However, there are several instances of high FENa (>2%) in cases of PRF and low FENa (<1%) in IRF patients. In contrast, the fractional excretion of urea nitrogen (FEUN) is primarily dependent on passive forces, and many confounding variables that affect FENa have little effect on FEUN, if any. To compare FEUN with FENa, pediatric patients with acute kidney injury (AKI) were prospectively evaluated by history, physical examination, and obtaining appropriate laboratory data during a 1-year interval. Diagnosis of PRF or IRF was made in each patient, and renal failure indices were compared between two groups using chi-square and t test, as appropriate. Probability value (P value) <0.05 was considered significant. Receiver operating characteristic (ROC) plots for FEUN and FENa were drawn to compare the discriminative power of each index. Forty-three patients were enrolled in the study. There were 27 patients in the PRF and 16 in the IRF group. FENa was 2 ± 0.4 in PRF and 4.5 ± 1% in IRF patients (P < 0.05), and low FENa (<1%) was only seen in 44.4% of PRF patients, which was not statistically different from those with IRF (P > 0.05). FEUN was 23.6 ± 4.9% in PRF and 41.6 ± 4.8% in IRF patients (P < 0.05), and low FEUN (<35%) was seen in 77.8% of the PRF group (P < 0.05). Cutoff values of 30% and 1.6% were reached for FEUN and FENa, respectively. In conclusion, FEUN < 35% had higher sensitivity and specificity than FENa < 1% for differentiation of PRF from IRF.


Nefrologia | 2012

NPHS2 gene mutation in an Iranian family with familial steroid-resistant nephrotic syndrome

Sonbol Ameli; Mojgan Mazaheri; Ameneh Zare-Shahabadi; Fatih Ozaltin; Fahimeh Asgarian; Maryam Monajemzadeh; Behnaz Bazargani; Nematollah Ataei; Niloofar Hajezadeh; Abbas Madani; Taher Esfahani; Anna Isaian; Martin Zenker; Nima Rezaei

1 Pediatrics Center of Excellence. Childrens Medical Center, Tehran University of Medical Sciences. Tehran (Iran) 2 Research Center for Immunodeficiencies. Childrens Medical Center, Tehran University of Medical Sciences. Tehran (Iran) 3 Department of Pediatrics. Faculty of Medicine, Hacettepe University. Ankara (Turkey) 4 Institute of Human Genetics, University Hospital of Magdeburg. Magdeburg (Germany) 5 Department of Immunology. Molecular Immunology Research Center, Research Center for Immunodeficiencies, Childrens Medical Center, Tehran University of Medical Sciences. Tehran (Iran)


Pediatric Nephrology | 2010

An infant presenting with a non-functional kidney on dimercaptosuccinic acid scan: answer

Neamatollah Ataei; Abbas Madani; Seyed Taher Esfahani; Alireza Sina; Abdol-Mohammad Kajbafzadeh; Maryam Monajemzadeh; Fatemeh Ataei

Owing to complete deterioration of the right kidney’s function, seen on dimercaptosuccinic acid (DMSA) scan, presence of severe hydronephrosis, and a large, enhanced, well-defined, hyperechoic mass with an inhomogeneous density in the lower pole of the right kidney, extending into the pelvis and proximal ureter, shown on the third renal ultrasound and computed tomography (CT), the initial differential diagnoses included: xanthogranulomatous pyelonephritis [1–3], malakoplakia [4–6], inflammatory pseudotumour of the renal pelvis [7–9], and fungal infection [10, 11]. In this patient, the preoperative diagnosis was not identified. Therefore, with the patient under general anaesthesia, a percutaneous sonography-guided biopsy of the renal mass was performed, and findings of an examination of a frozen section were compatible with Wilm’s tumour. The patient underwent a right radical nephroureterectomy via a hemitransverse incision of the upper abdomen on 15 July 2006. The resected specimen showed a large, polypoid, light-yellow, glistening mass located in the pelvicalyceal system, extending into the proximal ureter without invading the surrounding tissues (Fig. 5). Histopathological examination showed features of Wilms’ tumour, exhibiting both epithelial and mesenchymal differentiation (Fig. 6). Thus, a final diagnosis of intrapelvic Wilms’ tumour, stage I, was considered. The immunohistochemical findings were positive for the Wilms’ tumour 1 gene (WT-1) in the tumour cells, but staining with myogenin showed negative reaction. On 17 July 2006, 3 days after her nephrectomy, she developed cough, dyspnoea, and fever. Lung auscultation revealed rhonchi. A chest X-ray did not show any evidence of pneumonia, but it disclosed hypoplasia of the third right rib (Fig. 7). On 22 August 2006, due to the chronic cough, a barium swallow was performed and displayed significant gastro-oesophageal reflux. The patient received combination chemotherapy with dactinomycin (AMD) and vincristine (VCR), in accordance with the National Wilms’ Tumor Study (NWTS) IV protocol of stage. An abdominal ultrasonogram at the last follow up (50 days after nephrectomy) showed no mass lesions in the ovaries. Pediatr Nephrol (2010) 25:257–260 DOI 10.1007/s00467-009-1210-1


Cases Journal | 2009

Enalapril induced reversible acute renal failure detected by (99m)Tc-DMSA renal scan in a patient with bilateral renal artery stenosis: a case report.

Kianoush Ansari Gilani; Abbas Madani; Nahid Rahimzadeh; S T Esfahani; Jamak Modaresi Esfeh

The authors report and discuss a case of bilateral renal artery stenosis in a hypertensive 9 year-old girl that was first suspected with 99mTechnetium-dimercaptosuccinic acid renal scintigraphy. The scintigraphy showed signs of acute renal failure while the patient was on enalapril for controlling her hypertension. Bilateral renal artery stenosis was confirmed with computed tomography angiography. Hypertension resolved after bilateral renal artery angioplasty.


BANTAO Journal | 2016

Clinical Course of Children and Adolescents with Primary Vesicoureteral Reflux: A retrospective study of 958 patients

Abbas Madani; Yalda Ravanshad; Anoush Azarfar; Niloofar Hajizadeh; Nematollah Ataei; Zahra Adl; Zahra Pournasiri; Sepideh Bagheri; Sahar Ravanshad; Elham Samazghandi

Abstract Introduction. Vesicoureteral reflux (VUR) is the most common pediatric urologic abnormality and since it can predispose to urinary tract infection and resultant kidney scar it is an important issue in pediatric nephrourology. Methods. A retrospective chart review and follow-up of 958 patients with primary VUR was performed in the Children’s Medical Center, Tehran, Iran. Children with primary vesicoureteral reflux were included in the study and these parameters were studied: age, sex, clinical presentation, VUR grade, sonographic findings, DMSA changes, treatment modality (medical, surgical or endoscopic) and response to treatment, hypertension (presence/absence), urinary tract infection recurrence and development of new kidney scars in patients under medical treatment. Results. VUR was more prevalent in girls. Sonography was unable to detect VUR in many cases. Presence of renal scars was strongly associated with degree of reflux. Medical management was effective in a substantial percentage of patients and they experienced full resolution of reflux. This was especially true for lower degrees of VUR. 17.6% of patients developed new kidney scars on followup which was associated with higher degrees of VUR. Hypertension and breakthrough urinary tract infection was an uncommon finding in our patients. Conclusion. Medical management, which means using prophylactic antibiotics for prevention of urinary tract infection, is effective in many cases of VUR especially in cases with lower degrees of VUR. Surgical and endoscopic procedures must be reserved for patients with higher degrees of VUR unresponsive to conservative management or in whom new scars may develop.


Pediatric Nephrology | 2005

Evaluation of acute pyelonephritis with DMSA scans in children presenting after the age of 5 years

Neamatollah Ataei; Abbas Madani; Reza Habibi; Mosa Khorasani


Pediatric Nephrology | 2004

SCREENING FOR VESICOURETERAL REFLUX AND RENAL SCARS IN SIBLINGS OF CHILDREN WITH KNOWN REFLUX

Neamatollah Ataei; Abbas Madani; Seyed Taher Esfahani; Abdolmohammad Kejbafzadeh; Omid Ghaderi; Said Jalili; Bita Sharafi


Pediatric Nephrology | 2006

Serum zinc and copper levels in children with chronic renal failure.

Seyed Taher Esfahani; Mohammad Reza Hamidian; Abbas Madani; Neamatollah Ataei; P Mohseni; Moustafa Roudbari; Marzieh Haddadi

Collaboration


Dive into the Abbas Madani's collaboration.

Top Co-Authors

Avatar

Martin Zenker

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar

Ali Tourchi

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hassan Otoukesh

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Nahid Rahimzadeh

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Rozita Hoseini

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Zhina Sadeghi

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge